UPDATE : Friday, July 10, 2020
상단여백
HOME Policy
KHIDI, RIGHT Fund to cooperate on infectious disease research
  • By Shim Hyun-tai
  • Published 2020.05.25 17:02
  • Updated 2020.05.26 11:49
  • comments 0

The Korea Health Industry Development Institute (KHIDI) and RIGHT Fund, a three-way fund for public health promotion, agreed last Friday to step up cooperation on research and development (R&D) concerning infectious diseases.

The state-run agency and Research Investment for Global Health Technology (RIGHT) Fund – created by contributions from the government, some private companies, and the Bill & Melinda Gates Foundation -- signed a memorandum of understating on the sidelines of annual "Bio Korea 2020" event.

Kwon Deok-cheol (left), director of the Korea Health Industry Development Institute (KHIDI), and Moon Chang-jin, chairman of RIGHT Fund, signed an MOU to step up cooperation on research and development concerning infectious diseases at KHIDI last Friday.

Their goal is to support domestic R&D and promote international cooperation on new and endemic infectious diseases, the institute said in a press release.

Under the agreement, the institute and the fund will establish a channel that helps exchange R&D information of domestic health and medical technology before the RIGHT Fund's third project on medium- and large-scale research on infectious diseases begins.

The channel covers information on domestic healthcare technology on new infectious diseases, such as Covid-19, and endemic diseases in developing countries.

The two organizations agreed to cooperate on preparing measures to support research institutions and companies that struggle to respond to infectious diseases more effectively.

shim531@docdocdoc.co.kr

<© Korea Biomedical Review, All rights reserved.>

Other articles by Shim Hyun-tai
iconMost viewed
Comments 0
More
Please leave the first comment.
여백
여백
여백
Back to Top